β d n4 hydroxycytidine (MedChemExpress)
Structured Review

β D N4 Hydroxycytidine, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 49 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/β d n4 hydroxycytidine/product/MedChemExpress
Average 95 stars, based on 49 article reviews
Images
1) Product Images from "Loss of nsp14-exonuclease activity impairs the replication, proofreading, fitness and pathogenesis of SARS-CoV-2"
Article Title: Loss of nsp14-exonuclease activity impairs the replication, proofreading, fitness and pathogenesis of SARS-CoV-2
Journal: bioRxiv
doi: 10.64898/2026.01.12.698941
Figure Legend Snippet: VTA cells were infected with nanoluciferase-expressing SARS-CoV-2 WT or AA at 37°C at an MOI of 0.1 for 1hr after which input was removed, monolayers were washed and then exposed to a dose response of 5-fluorouracil (5-FU), β-d-N4-Hydroxycytidine (NHC, EIDD-1931) or GS-441524 in Infection Media. Concurrently, non-infected cells were treated similarly to determine cytotoxicity. After 24hr, viral replication was assessed by NanoGlo Luciferase Assay System (Promega) and cytotoxicity was determined by CellTiterGlo Assay (Promega). Each condition was evaluated in triplicate in two independent studies. Values were normalized to the uninfected and infected vehicle DMSO controls (0 and 100% infection, respectively). Data were fit using a four-parameter nonlinear regression analysis using GraphPad Prism. EC50 and CC50 (cytotoxic concentration at which 50% of cells are viable) values were then determined as the concentration reducing the signal by 50%.
Techniques Used: Infection, Expressing, Luciferase, Concentration Assay